Pathophysiology of anaemia: focus on the heart and blood vessels
- PMID: 11032352
- DOI: 10.1093/oxfordjournals.ndt.a027970
Pathophysiology of anaemia: focus on the heart and blood vessels
Abstract
The amount of oxygen delivered to an organ depends on three factors: blood flow and its distribution; the oxygen-carrying capacity of the blood, i.e. haemoglobin concentration; and oxygen extraction. Non-haemodynamic and haemodynamic mechanisms operate to compensate for anaemia. Non-haemodynamic mechanisms include increased erythropoietin production to stimulate erythropoiesis, and increased oxygen extraction (displacement of the haemoglobin oxygen dissociation curve). This decreased affinity of oxygen for haemoglobin is mediated by increased 2,3-diphosphoglycerate concentrations. Increased cardiac output is the main haemodynamic factor, mediated by lower afterload, increased preload, and positive inotropic and chronotropic effects. Decreased afterload is due to vasodilatation and reduced vascular resistance as a consequence of lower blood viscosity, hypoxia-induced vasodilatation, and enhanced nitric oxide activity. Vasodilatation also involves recruitment of microvessels and, in the case of chronic anaemia, stimulation of angiogenesis. With decreased afterload, the venous return (preload) and left ventricular (LV) filling increase, leading to increased LV end-diastolic volume and maintenance of a high stroke volume and high stroke work. High stroke work is also due to enhanced LV contractility attributed to increased concentrations of catecholamines and non-catecholamine inotropic factors. In addition, heart rate is increased in anaemia, due to hypoxia-stimulated chemoreceptors and increased sympathetic activity. In the long term, these haemodynamic alterations lead to gradual development of cardiac enlargement and LV hypertrophy (LVH). The LVH is eccentric, characterized by increased LV internal dimensions and a normal ratio of wall thickness to cavity diameter, as occurs in other forms of volume overload. When anaemia-related LVH develops in an otherwise 'healthy' humoral environment, the lesions are reversible and the type of LVH is primarily physiological and is not associated with impaired diastolic function. In the absence of underlying cardiovascular disorders, severe anaemia (Haemoglobin concentration < 4-5 g/dl) leads to congestive heart failure. In the presence of heart disease, especially coronary artery disease, anaemia intensifies angina and contributes to a high incidence of cardiovascular complications. In end-stage renal disease (ESRD), LVH is influenced by many other factors, leading to intense interstitial fibrosis, to alterations in diastolic function, and usually to poor reversibility. The chronic increase in cardiac output contributes to arterial remodelling of central elastic arteries such as the aorta and common carotid artery. This remodelling consists principally of arterial enlargement and compensatory arterial intima--media thickening. In ESRD, these geometric changes are accompanied by arterial stiffening. The principal consequences of arterial alterations are increased systolic pressure and high inertia due to higher blood mass in the dilated arterial system. These alterations contribute to the development of LVH and abnormal coronary perfusion.
Similar articles
-
Pathophysiology of cardiovascular damage in the early renal population.Nephrol Dial Transplant. 2001;16 Suppl 2:3-6. doi: 10.1093/ndt/16.suppl_2.3. Nephrol Dial Transplant. 2001. PMID: 11369841
-
Left ventricular alterations and end-stage renal disease.Nephrol Dial Transplant. 2002;17 Suppl 1:29-36. doi: 10.1093/ndt/17.suppl_1.29. Nephrol Dial Transplant. 2002. PMID: 11812909 Review.
-
Anaemia in end-stage renal disease: pathophysiological considerations.Nephrol Dial Transplant. 2001;16 Suppl 7:2-8. doi: 10.1093/ndt/16.suppl_7.2. Nephrol Dial Transplant. 2001. PMID: 11590249 Review.
-
What are the short-term and long-term consequences of anaemia in CRF patients?Nephrol Dial Transplant. 1999;14 Suppl 2:29-36. doi: 10.1093/ndt/14.suppl_2.29. Nephrol Dial Transplant. 1999. PMID: 10334665 Review.
-
Vascular disease and atherosclerosis in uremia.Nefrologia. 2005;25 Suppl 2:91-5. Nefrologia. 2005. PMID: 16050410
Cited by
-
Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease.BMC Pregnancy Childbirth. 2024 Feb 16;24(1):141. doi: 10.1186/s12884-023-06232-x. BMC Pregnancy Childbirth. 2024. PMID: 38365664 Free PMC article.
-
Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure.Medicina (Kaunas). 2024 Jan 1;60(1):84. doi: 10.3390/medicina60010084. Medicina (Kaunas). 2024. PMID: 38256345 Free PMC article.
-
Anemia and Iron Deficiency Predict All-Cause Mortality in Patients with Heart Failure and Preserved Ejection Fraction: 6-Year Follow-Up Study.Diagnostics (Basel). 2024 Jan 18;14(2):209. doi: 10.3390/diagnostics14020209. Diagnostics (Basel). 2024. PMID: 38248085 Free PMC article.
-
Pathophysiological concepts and screening of cardiovascular disease in dialysis patients.Front Nephrol. 2023 Sep 29;3:1198560. doi: 10.3389/fneph.2023.1198560. eCollection 2023. Front Nephrol. 2023. PMID: 37840653 Free PMC article. Review.
-
Left atrioventricular interaction and impaired left atrial phasic function in type 2 diabetes mellitus patients with or without anemia: a cardiac magnetic resonance study.Cardiovasc Diabetol. 2023 Jul 13;22(1):178. doi: 10.1186/s12933-023-01910-8. Cardiovasc Diabetol. 2023. PMID: 37443014 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
